Align Technology
ALGN · Health Care Supplies
$154.51
0.6%Cooper Companies
COO · Health Care Supplies
$61.21
0.7%The short version
- Cooper Companies is the larger business, with $4.1B of revenue in fiscal 2025 against $4.0B for Align Technology.
- Cooper Companies grew revenue faster (5.1%, against 0.9%).
- Cooper Companies kept more of each dollar of sales as operating profit (16.7% operating margin, against 13.5% operating margin).
- Align Technology turned more of its sales into free cash flow (12.2% FCF margin, against 10.6% FCF margin).
- Align Technology earned a higher return on the capital invested in it (13.3%, against 4.3%).
- Investors pay more for each dollar of Align Technology’s earnings: a P/E of 26.9x against 21.0x for Cooper Companies.
| Latest fiscal year | ALGN · FY25 | COO · FY25 |
|---|---|---|
| Size | ||
| Market cap | $11.0B | $11.8B |
| Revenue | $4.0B | $4.1B |
| Free cash flow | $491M | $434M |
| Net income | $410M | $375M |
| Growth | ||
| Revenue growth | 0.9% | 5.1% |
| 5-year growth | 10.3% | 11.0% |
| Share count change | −3.2% | −0.2% |
| Profitability | ||
| Gross margin | 67.2% | 65.5% |
| Operating margin | 13.5% | 16.7% |
| Net margin | 10.2% | 9.2% |
| FCF margin | 12.2% | 10.6% |
| Return on capital | 13.3% | 4.3% |
| Return on equity | 10.4% | 4.6% |
| Balance sheet | ||
| Net debt | −$1.1B | $2.4B |
| Net debt / EBITDA | −1.4x | 2.3x |
| Dividends and buybacks | $466M | $290M |
| Valuation & quality | ||
| P/E | 26.9x | 21.0x |
| Piotroski F-score | 5 | 5 |
FY16
ALGN $1.1B
COO $2.0B
FY17
ALGN $1.5B
COO $2.1B
FY18
ALGN $2.0B
COO $2.5B
FY19
ALGN $2.4B
COO $2.7B
FY20
ALGN $2.5B
COO $2.4B
FY21
ALGN $4.0B
COO $2.9B
FY22
ALGN $3.7B
COO $3.3B
FY23
ALGN $3.9B
COO $3.6B
FY24
ALGN $4.0B
COO $3.9B
FY25
ALGN $4.0B
COO $4.1B
ALGN
COO
FY16
ALGN 23.1%
COO 16.5%
FY17
ALGN 24.0%
COO 20.1%
FY18
ALGN 23.7%
COO 15.9%
FY19
ALGN 22.5%
COO 20.6%
FY20
ALGN 15.7%
COO 12.8%
FY21
ALGN 24.7%
COO 17.3%
FY22
ALGN 17.2%
COO 15.3%
FY23
ALGN 16.7%
COO 14.8%
FY24
ALGN 15.2%
COO 18.1%
FY25
ALGN 13.5%
COO 16.7%
ALGN
COO
FY16
ALGN $177M
COO $357M
FY17
ALGN $243M
COO $466M
FY18
ALGN $331M
COO $475M
FY19
ALGN $598M
COO $421M
FY20
ALGN $507M
COO $176M
FY21
ALGN $771M
COO $524M
FY22
ALGN $277M
COO $450M
FY23
ALGN $608M
COO $215M
FY24
ALGN $623M
COO $288M
FY25
ALGN $491M
COO $434M
ALGN
COO
FY16
ALGN 57.8%
COO 7.4%
FY17
ALGN 57.5%
COO 9.7%
FY18
ALGN 86.1%
COO 4.2%
FY19
ALGN 87.3%
COO 10.6%
FY20
ALGN 28.2%
COO 5.6%
FY21
ALGN 31.5%
COO 7.6%
FY22
ALGN 15.4%
COO 4.6%
FY23
ALGN 17.0%
COO 3.8%
FY24
ALGN 15.4%
COO 4.6%
FY25
ALGN 13.3%
COO 4.3%
ALGN
COO
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.